OOIR: Observatory of International Research

Papers

(The H4-Index of JACC-Cardiovascular Imaging is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging	411
Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19	310
Right Ventricular Dilation in Hospitalized Patients With COVID-19 Infection	157
How to Image Cardiac Amyloidosis	149
High Prevalence of Pericardial Involvement in College Student Athletes Recovering From COVID-19	146
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction	138
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis	134
Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation (PRIME): A Checklist	118
Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression	117
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure	113
Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19	104
Myocardial Tissue Characterization and Fibrosis by Imaging	104
Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers	99
Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature	99
A Cardiac Computed Tomography–Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization	91
Myocardial Infarction Associates With a Distinct Pericoronary Adipose Tissue Radiomic Phenotype	81
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis	78
Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis	78
Cardiovascular Magnetic Resonance for Patients With COVID-19	76
The Mitral Annular Disjunction of Mitral Valve Prolapse	76
CT FFR for Ischemia-Specific CAD With a New Computational Fluid Dynamics Algorithm	74
Feature Tracking Myocardial Strain Incrementally Improves Prognostication in Myocarditis Beyond Traditional CMR Imaging Features	73
Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension	71
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis	65
Impact of Right Ventricular Dysfunction on Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation	65

Heart and Lung Multimodality Imaging in COVID-19	64
Identifying Cardiac Amyloid in Aortic Stenosis	64
High-Resolution Cardiac Magnetic Resonance Imaging Techniques for the Identification of Coronary Microvascular Dysfunction	62
3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease	61
Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events	61
Prognostic Impact of Ischemic Mitral Regurgitation Severity and Myocardial Infarct Quantification by Cardiovascular Magnetic Resonance	61
Neo-LVOT and Transcatheter Mitral Valve Replacement	60
Imaging-Guided Therapies for Pericardial Diseases	59
Warranty Period of a Calcium Score of Zero	59
DPD Quantification in Cardiac Amyloidosis	59
Artificial Intelligence for Automatic Measurement of Left Ventricular Strain in Echocardiography	58
Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance	58
OCT and CMR for the Diagnosis of Patients Presenting With MINOCA and Suspected Epicardial Causes	57
Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes	56
Deep-Learning Models for the Echocardiographic Assessment of Diastolic Dysfunction	55
Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA	54
Association of Asymptomatic Diastolic Dysfunction Assessed by Left Atrial Strain With Incident Heart Failure	54
Cardiac Magnetic Resonance Characterization of Myocarditis-Like Acute Cardiac Syndrome in COVID-19	54
Prognostic Value of Coronary CTA in Stable Chest Pain	54
Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic	53
Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis	53
Ultrafast Ultrasound Imaging in Pediatric and Adult Cardiology	52
Coronary Artery Calcification and Complications in Patients With COVID-19	52
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease	52
Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography	52
Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths	51